O’Reilly et al., “Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.” Drug Discovery Today, 2019; Doi.org/10.1016/j.drudis.2019.03.009

O’Reilly et al., “Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.” Drug Discovery Today, 2019; Doi.org/10.1016/j.drudis.2019.03.009